Stephen Mayo

Insider Reports History

Location
2000 Galloping Hill Rd, Kenilworth, NJ
Signature
/s/Earl Douglas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Mayo:

Insider Reports Filed by Stephen Mayo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALLO Allogene Therapeutics, Inc. Jun 18, 2025 1 $0 4 Jun 23, 2025 Director
MRK Merck & Co., Inc. May 30, 2025 1 $220K 4 Jun 3, 2025 Director
SRPT Sarepta Therapeutics, Inc. Mar 10, 2025 2 $0 4 Mar 11, 2025 Director
ALLO Allogene Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
MRK Merck & Co., Inc. May 31, 2024 1 $220K 4 Jun 4, 2024 Director
SRPT Sarepta Therapeutics, Inc. Mar 5, 2024 1 -$385K 4 Mar 6, 2024 Director
SRPT Sarepta Therapeutics, Inc. Mar 1, 2024 2 $0 4 Mar 5, 2024 Director
ALLO Allogene Therapeutics, Inc. Aug 7, 2023 1 -$42.9K 4 Aug 9, 2023 Director
ALLO Allogene Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
MRK Merck & Co., Inc. May 26, 2023 1 $220K 4 May 31, 2023 Director
SRPT Sarepta Therapeutics, Inc. Mar 6, 2023 2 $0 4 Mar 8, 2023 Director
SRPT Sarepta Therapeutics, Inc. Nov 17, 2022 1 -$94.3K 4 Nov 21, 2022 Director
ALLO Allogene Therapeutics, Inc. Jul 8, 2022 2 $0 4 Jul 12, 2022 Director
ALLO Allogene Therapeutics, Inc. Jul 8, 2022 0 $0 3 Jul 12, 2022 Director
MRK Merck & Co., Inc. May 27, 2022 1 $220K 4 Jun 1, 2022 Director
SRPT Sarepta Therapeutics, Inc. Mar 7, 2022 2 $0 4 Mar 9, 2022 Director
SRPT Sarepta Therapeutics, Inc. Nov 16, 2021 2 $0 4 Nov 17, 2021 Director
SRPT Sarepta Therapeutics, Inc. Nov 16, 2021 0 $0 3 Nov 17, 2021 Director
MRK Merck & Co., Inc. May 28, 2021 1 $200K 4 Jun 2, 2021 Director